Literature DB >> 3399988

Fusarium moniliforme contamination of maize in oesophageal cancer areas in Transkei.

W F Marasas1, K Jaskiewicz, F S Venter, D J Van Schalkwyk.   

Abstract

The prevalence of human oesophageal cytological abnormalities was determined by means of brush biopsy capsules in the adult occupants of each of 12 households in a low, an intermediate and a high oesophageal cancer rate area in Transkei during 1985 and 1986. Mild cellular changes (folic acid deficiency, atypia and mild dysplasia) as well as advanced changes (dysplasia and cancer) occurred more frequently in the occupants of households in high than in intermediate and low oesophageal cancer rate areas. The prevalence of fungi in homegrown maize from the households in each area was determined by plating surface-sterilized kernels on agar. The prevalence of Fusarium moniliforme was significantly higher (P less than 0.01) in maize from cytologically 'affected' households in the high oesophageal cancer rate area than from 'unaffected' households in the low oesophageal cancer rate area during both seasons. These results confirm previous reports on the difference in the prevalence of F. moniliforme in maize from low and high oesophageal cancer rate areas in Transkei. Whereas the previously established correlation was between F. moniliforme and oesophageal cancer rate, the present results provide evidence for an association between this fungus and oesophageal cytological abnormalities in living individuals. These people will be included in further clinical, epidemiological and aetiological studies.

Entities:  

Mesh:

Year:  1988        PMID: 3399988

Source DB:  PubMed          Journal:  S Afr Med J


  44 in total

1.  In vitro toxicology of fumonisins and the mechanistic implications.

Authors:  W P Norred; E Wang; H Yoo; R T Riley; A H Merrill
Journal:  Mycopathologia       Date:  1992-02       Impact factor: 2.574

2.  Differential cytotoxicity and mycotoxin content among isolates of Fusarium moniliforme.

Authors:  W P Norred; C W Bacon; R D Plattner; R F Vesonder
Journal:  Mycopathologia       Date:  1991-07       Impact factor: 2.574

3.  Risk-assessment implications of mechanistic model's prediction of low-dose nonlinearity of liver tumor risk for mice fed fumonisin b(1).

Authors:  Ralph L Kodell; Angelo Turturro
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-01

4.  Comparative cytotoxicity of fumonisin B1 in two cell lines derived from normal human bronchial epithelial cells using four distinct bioassay techniques.

Authors:  C Lewis; J Smith; J Anderson; R Freshney
Journal:  Mycotoxin Res       Date:  1999-06       Impact factor: 3.833

5.  Mutagenicity of potentially carcinogenic mycotoxins produced byFusarium moniliforme.

Authors:  W C Gelderblom; S D Snyman
Journal:  Mycotoxin Res       Date:  1991-09       Impact factor: 3.833

6.  Survey of fumonisin production by Fusarium species.

Authors:  P G Thiel; W F Marasas; E W Sydenham; G S Shephard; W C Gelderblom; J J Nieuwenhuis
Journal:  Appl Environ Microbiol       Date:  1991-04       Impact factor: 4.792

7.  Fumonisins and Alternaria alternata lycopersici toxins: sphinganine analog mycotoxins induce apoptosis in monkey kidney cells.

Authors:  W Wang; C Jones; J Ciacci-Zanella; T Holt; D G Gilchrist; M B Dickman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

8.  Field performance of maize grown from Fusarium verticillioides-inoculated seed.

Authors:  I E Yates; N W Widstrom; C W Bacon; A Glenn; D M Hinton; D Sparks; A J Jaworski
Journal:  Mycopathologia       Date:  2005-01       Impact factor: 2.574

9.  Lack of micronuclei induction by fumonisin B(1) mycotoxin in BALB/c mice.

Authors:  Rupula Karuna; B Sashidhar Rao
Journal:  Mycotoxin Res       Date:  2012-10-23       Impact factor: 3.833

10.  Proteome analysis of Aspergillus niger: lactate added in starch-containing medium can increase production of the mycotoxin fumonisin B2 by modifying acetyl-CoA metabolism.

Authors:  Louise M Sørensen; Rene Lametsch; Mikael R Andersen; Per V Nielsen; Jens C Frisvad
Journal:  BMC Microbiol       Date:  2009-12-10       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.